Lessons learned: How Jeff Karp stays at the forefront of innovation
Serial entrepreneur Jeff Karp has a philosophy for his laboratory: find important problems and get solutions to people quickly. To learn about the exciting technologies emerging from Karp’s lab, join us at DeviceTalks Boston on Oct. 8-10.
After Jeff finished his PhD in chemical and biomedical engineering at the University of Toronto, he knew he wanted to work with Robert Langer.
“He’s the intergalactic translational superstar,” Karp said.
Langer, a professor at the Massachusetts Institute of Technology and one of the most cited engineers of all time, receives thousands of applications per year from people looking ...
Source: Mass Device - August 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Research & Development DeviceTalks Boston Frequency Therapeutics Source Type: news
New Thinking Informs Soft-Material 3D Printing
As 3D printing evolves, researchers have gone beyond mere fabrication processes to developing techniques for optimizing how particular materials can be printed. To that end, researchers at Carnegie Mellon University’s College of Engineering have developed a new approach to optimizing the 3D printing of soft materials. This approach combines expert judgment with an algorithm designed to search parameter combinations relevant for 3D printing, they said.
Images of 3D prints made using a new method developed by researchers at Carnegie Mellon. Their approach combines expertise with an algorithm an...
Source: MDDI - August 8, 2018 Category: Medical Devices Tags: Design News Source Type: news
Tackling drug delivery challenges with TissueGen ’s implantable fibers
TissueGen‘s chief scientist and co-founder, Kevin Nelson, told Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber.
DDBN: How did TissueGen get its start?
Nelson: In 1996, while faculty in biomedical engineering at The University of Texas at Arlington, I was working with Dr. Robert Eberhart at the University of Texas Southwestern Medical Center at Dallas. Together, we collaborated with a team to develop a biodegradable vascular stent that had the potential to deliver a live virus to the arterial wall. Simultaneously, I was working with Dr. ...
Source: Mass Device - August 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Implants Pharmaceuticals TissueGen Source Type: news
Women and lupus -- Tackling the debilitating connection
(University of Houston) The chronic inflammatory disease, lupus, is about nine times more common in women than men, and now one of the leading lupus researchers in the world, UH biomedical engineering professor Chandra Mohan, has been awarded $2 million to find out why. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 31, 2018 Category: International Medicine & Public Health Source Type: news
Enrico Gratton to receive 2019 BPS Avanti Award in Lipids
(Biophysical Society) The Biophysical Society (BPS) has named Enrico Gratton, Professor, Department of Biomedical Engineering, University of California, Irvine, as its 2019 Avanti Award in Lipids winner. Gratton will be honored at the Society's 63rd Annual Meeting at the Baltimore Convention Center on March 5, 2019, during the annual Awards Symposium. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 30, 2018 Category: Biology Source Type: news
This engineered heart ventricle helps with studying arrhythmia and cardiomyopathy
[Luke MacQueen and Michael Rosnach/Harvard University]While engineered heart tissues can replicate muscle contraction and electrical activity in a dish, many aspects of heart disease can only adequately be captured in 3D. In a report published online yesterday by Nature Biomedical Engineering, researchers describe a scale model of a heart ventricle, built to replicate the chamber’s architecture, physiology and contractions. Cardiac researchers at Boston Children’s Hospital think it could help them find treatments for congenital heart diseases.
Building a 3D engineered heart ventricle
Collaborators from the Harvard Scho...
Source: Mass Device - July 26, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog Vector Blog Source Type: news
Leading experts in diabetes, metabolism and biomedical engineering discuss precision medicine
(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) New technologies enable deeper insights into the causes of major diseases such as diabetes, obesity or cancer and open the way to a new generation of diagnostics and therapies. For the first time, the new Helmholtz Pioneer Campus (HPC) at Helmholtz Zentrum M ü nchen and the German Center for Diabetes Research (DZD) have invited bioengineers, diabetes researchers and scientists from related therapeutic areas to the International Conference on Engineering Biomedical Breakthroughs on the island of San Servolo in the Venice Lagoon. (Source: Eurek...
Source: EurekAlert! - Medicine and Health - July 12, 2018 Category: International Medicine & Public Health Source Type: news
Breast implant makers Polytech, G & G ink stock-swap merger pact
Silicone breast-implant makers Polytech Health & Aesthetics and G&G Biotechnology are getting together in a stock-swap merger.
G&G designed the world’s first lightweight breast implant, the B-Lite, to reduce the impact of gravity on the reconstructed or augmented breast using technology developed by NASA to make its implants up to 30% lighter. The company sells its products in more than 30 countries, not including the U.S.
Plastic surgeon Dr. Jacky Govrin and his brother, biomedical engineer Dael Govreen-Segal, founded G&G in Haifa in 2005. Polytech, which makes 2,000 varieties of breast implants,...
Source: Mass Device - July 9, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Implants Mergers & Acquisitions G&G Biotechnology Polytech Health & Aesthetics Source Type: news
The NHS needs a new breed of innovator for the information age | Kevin Fong
Technology is never going to replace doctors - or make healthcare cheaper. But data and artificial intelligence are the futureFrom vaccines and antibiotics tomemory metal stents that widen narrowed arteries and algorithms that process radiological images and let us see the earliest signs of disease,innovation has been saving lives since the inception of theNational Health Service 70 years ago. It is this blend of new molecules, materials science and biomedical engineering, in partnership with digital systems, that will continue to transform our expectations of life and survival in the 21st century.While the digital revolut...
Source: Guardian Unlimited Science - July 6, 2018 Category: Science Authors: Kevin Fong Tags: NHS Technology Health Medical research Science Society UK news Source Type: news
Abbott launches program to offset employee student loan debt
Abbott (NYSE:ABT) said today it is launching a program to aid its employees with paying off their student loans.
The new program, labeled the Freedom 2 Save program, will allow certain employees to receive matched deposits into savings program to match contributions meant to offset student loan debt.
“We see our young professionals coming to us with a problem: Student loan debt payments keep them from setting aside the money they’d like to put in savings for retirement. With every decade you wait to start saving for retirement, the amount you need to save roughly doubles. This plan will give participants savi...
Source: Mass Device - June 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Abbott Source Type: news
Texas A & M research opens doors to expanded DNA studies
(Texas A&M University) Dr. Wonmuk Hwang, associate professor in the Department of Biomedical Engineering at Texas A&M University, is researching the mechanics of DNA, the blueprint of the human body. Hwang and his former doctoral student, Dr. Xiaojing Teng, zoomed into the question: if the genetic information is the same in all cells, as it should be, why do muscle cells look and act differently than skin cells? (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 26, 2018 Category: Biology Source Type: news
The seed that could bring clean water to millions
(College of Engineering, Carnegie Mellon University) Carnegie Mellon University's Biomedical Engineering and Chemical Engineering Professors Bob Tilton and Todd Przybycien recently co-authored a paper with Ph.D. students Brittany Nordmark and Toni Bechtel, and alumnus John Riley, further refining a process that could soon help provide clean water to many in water-scarce regions. The process, created by Tilton's former student and co-author Stephanie Velegol, uses sand and plant materials readily available in many developing nations. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 20, 2018 Category: International Medicine & Public Health Source Type: news
UH scientist working toward a glaucoma cure
(University of Houston) With $765,000 from the National Institutes of Health, University of Houston College of Optometry biomedical engineer Vijaykrishna Raghunathan is working towards a pharmaceutical cure for the irreversible disease Glaucoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news
Have Johns Hopkins Biomedical Engineering Students Solved The Nuisance Of Nasal Congestion?
A team of five biomedical engineering undergraduates at John Hopkins University (JHU) plan to manufacture and sell a device that they say would achieve the same effect as nasal reconstructive surgery for sufferers of chronic nasal obstruction - a condition that affects tens of millions of Americans. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 19, 2018 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news
Researchers deliver cardiac stem cell therapy in preclinical trial using refillable patch
Researchers have developed a small device designed to halt the effects of a heart attack by delivering a stem cell therapy directly to damaged cardiac tissue.
In a study published in Nature Biomedical Engineering, researchers from Harvard University, the Massachusetts Institute of Technology, the National University of Ireland Galway and Trinity College Dublin reported that the device improved heart function in rats that received multiple doses of the stem cell therapy over the course of four weeks.
Get the full story at our sister site, Drug Delivery Business News.
The post Researchers deliver cardiac stem cell therapy i...
Source: Mass Device - June 11, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Drug-Device Combinations Pharmaceuticals Research & Development Harvard University Massachusetts Institute of Technology Source Type: news
